Arpeggio Bio

Arpeggio Bio is a biotechnology company focused on developing innovative therapies for lung cancer and other diseases by targeting complex biological networks rather than relying on a single target. This approach allows the company to address challenges associated with 'undruggable' transcription factors, which are often difficult to target using traditional drug discovery methods. The company aims to create new treatments that can effectively intervene in these complex biological systems, potentially leading to breakthroughs in cancer therapy and beyond.

The team at Arpeggio Bio is composed…